Literature DB >> 10442424

Five-year analysis of antimicrobial susceptibility of the Streptococcus milleri group.

A Limia1, M L Jiménez, T Alarcón, M López-Brea.   

Abstract

Susceptibility to 17 antibiotics was studied in 180 strains of the Streptococcus milleri group (88 Streptococcus anginosus, 63 Streptococcus constellatus, and 29 Streptococcus intermedius) isolated over a 5-year period. Minimum inhibitory concentrations of penicillin were in the intermediate range for 5.6% of the strains. Resistance to erythromycin and clindamycin was found in 17.1% and 16.6% of the isolates, respectively. A steady increase in the susceptibility to ciprofloxacin was observed over the study period. Imipenem was the most active beta-lactam agent tested. Glycopeptide antibiotics showed excellent activity. Only slight differences between the three species were found in terms of antibiotic susceptibility. Intermediate resistance to penicillin is appearing among the Streptococcus milleri group in our area; consequently, care must be taken when choosing a macrolide for the management of infections caused by these microorganisms.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10442424     DOI: 10.1007/s100960050315

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  11 in total

1.  Prevalence of macrolide resistance genes in clinical isolates of the Streptococcus anginosus ("S. milleri") group.

Authors:  J A Jacobs; G J van Baar; N H London; J H Tjhie; L M Schouls; E E Stobberingh
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

Review 2.  Streptococcal infections in patients with chronic granulomatous disease: case report and review of the literature.

Authors:  E Liana Falcone; Stephan Hanses; Frida Stock; Steven M Holland; Adrian M Zelazny; Gulbu Uzel
Journal:  J Clin Immunol       Date:  2012-02-29       Impact factor: 8.317

3.  Antibiotic susceptibilities of genetically characterized Streptococcus milleri group strains.

Authors:  M Tracy; A Wanahita; Y Shuhatovich; E A Goldsmith; J E Clarridge; D M Musher
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

4.  Macrolide and clindamycin resistance in Streptococcus milleri group isolates from the airways of cystic fibrosis patients.

Authors:  Margot E Grinwis; Christopher D Sibley; Michael D Parkins; Christina S Eshaghurshan; Harvey R Rabin; Michael G Surette
Journal:  Antimicrob Agents Chemother       Date:  2010-04-19       Impact factor: 5.191

Review 5.  What happened to the streptococci: overview of taxonomic and nomenclature changes.

Authors:  Richard Facklam
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

Review 6.  The role of Streptococcus intermedius in brain abscess.

Authors:  A K Mishra; P-E Fournier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-11-28       Impact factor: 3.267

7.  Prevalence of β-hemolytic groups C and F streptococci in patients with acute pharyngitis.

Authors:  Alaa H Al-Charrakh; Jawad K T Al-Khafaji; Rana H S Al-Rubaye
Journal:  N Am J Med Sci       Date:  2011-03

8.  Use of an Intracranial Drain as a Conduit for Treatment of an Intracranial Streptococcus intermedius Abscess.

Authors:  Shoeb B Lallani; Melanie Hyte; Emily Trieu; Carlos Reyes-Sacin; Ninh Doan
Journal:  Cureus       Date:  2021-04-21

9.  Postoperative Streptococcus constellatus Bacteremia in a 75-Year-Old Patient with Pyometra: A Case Report.

Authors:  Alessia Sala; Stefano Restaino; Chiara De Carlo; Martina Comand; Alberto Frigo; Samuele Martínez Rivero; Elisa Zanetti; Lorenza Driul
Journal:  Am J Case Rep       Date:  2021-06-24

10.  Streptococcus milleri and Recurrent Intra-Abdominal Abscesses: A Case Report and Literature Review.

Authors:  Tabitha M Gana; Olugbenga Awolaran; Sobia Akhtar
Journal:  Case Rep Surg       Date:  2016-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.